(Q40880162)

24 September 2017

1 reference

title

Are methods for estimating QALYs in cost-effectiveness analyses improving? (English)

1 reference

24 September 2017

P J Neumann

1

1 reference

24 September 2017

D E Zinner

series ordinal

2

1 reference

24 September 2017

J C Wright

series ordinal

3

1 reference

24 September 2017

1 October 1997

1 reference

24 September 2017

Medical Decision Making

1 reference

24 September 2017

17

1 reference

24 September 2017

4

1 reference

24 September 2017

402-408

1 reference

Should QALYs be programme-specific?

24 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700405

Toward quality assurance in QALY calculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700405

Cost-per-QALY league tables: their role in pharmacoeconomic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700405

Economic analysis as an aid to subsidisation decisions: the development of Australian guidelines for pharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700405

Cost-utility in practice: a policy maker's guide to the state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700405

Foundations of Cost-Effectiveness Analysis for Health and Medical Practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700405

Healthy-years equivalents versus quality-adjusted life years: in pursuit of progress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700405

A scale of valuations of states of illness: is there a social consensus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700405

Measurement of health state utilities for economic appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700405

Multi-attribute health status classification systems. Health Utilities Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700405

Multi-attribute preference functions. Health Utilities Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700405

EuroQol--a new facility for the measurement of health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700405

A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700405

Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700405

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700405

Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700405

Cost-effectiveness league tables: More harm than good?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700405

10.1177/0272989X9701700405

21 January 2018

Identifiers

DOI

0 references

1 reference